Related Experiment Video
Updated: Jun 5, 2025
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
Prognostic model and immune-infiltrating cell landscape based on differentially expressed autophagy-related genes in
Yan-Hua Zheng1,2,3, Hong-Yuan Shen1, Xiang Chen4
1Department of Hematology, Xijing Hospital, Fourth Military Medical University (Air Force Medical University), Xi'an, Shaanxi, China.
Introduction:
Autophagy functions as a prosurvival mechanism in multiple myeloma (MM). The objective of this research was to establish an autophagy-related gene (ARG) signature for predicting the survival outcomes of MM patients with TP53 mutations.
Material And Methods:
Information about MM patients with TP53 mutations was downloaded from the Gene Expression Omnibus (GEO) database. Cox proportional hazard regression was employed to determine the independent prognostic ARG and construct a risk signature. Time-dependent receiver-operating characteristic (tROC) curve analysis was used to explore the predictive accuracy of the prognostic model. A nomogram was constructed to give a more precise prediction of the probability of 5-year, 8-year and 10-year overall survival (OS). In addition, we used the CIBERSORT algorithm to explore the distribution difference of 22 immune-infiltrating cells.
Results:
Three differentially expressed ARGs (CASP8, MAPK8, RB1CC1) were finally incorporated to construct the risk model. Area under the curve (AUC) values of the corresponding tROC curve for 5-year, 8-year and 10-year OS were 0.735, 0.686 and 0.662, respectively. Multiple myeloma patients were categorized into high and low-risk groups in accordance with the median threshold value (-1.724549). An ARG-based risk score model was an independent prognostic element correlated with OS, giving an hazard ratio (HR) of 3.29 (95% CI 2.35-4.60, p < 0.001). Thirteen immune infiltrating cells were found to have distribution differences between the two groups.
Conclusions:
We established a three-ARG risk signature which manifested an independent prognostic factor. The nomogram was testified to perform well in forecasting the long-term survival of TP53-mutated MM patients.
